5.0
Nov 22, 2021
Current employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
Cutting edge science Stem cell therapy bringing into Pharma industry Great people to work with
Cons
Early stages a lot of areas to define in novel pharma space